Article Details
Retrieved on: 2021-12-07 13:17:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The NurOwn® technology platform (autologous MSC-NTF cells) represents a promising investigational therapeutic approach to targeting disease ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here